MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 161 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2014. The put-call ratio across all filers is 4.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $231,000 | -28.5% | 16,760 | -8.2% | 0.02% | -36.0% |
| Q4 2016 | $323,000 | -60.6% | 18,260 | -57.0% | 0.02% | -60.3% |
| Q3 2016 | $820,000 | -17.9% | 42,510 | -12.3% | 0.06% | -27.6% |
| Q1 2016 | $999,000 | -9.8% | 48,450 | -10.2% | 0.09% | -11.2% |
| Q4 2015 | $1,107,000 | +11.4% | 53,950 | -7.2% | 0.10% | -4.9% |
| Q3 2015 | $994,000 | -9.6% | 58,150 | -1.4% | 0.10% | -1.9% |
| Q2 2015 | $1,099,000 | -2.3% | 58,950 | 0.0% | 0.10% | -5.4% |
| Q1 2015 | $1,125,000 | +16.0% | 58,950 | 0.0% | 0.11% | +5.7% |
| Q4 2014 | $970,000 | -58.5% | 58,950 | -55.4% | 0.10% | -61.4% |
| Q3 2014 | $2,336,000 | -14.3% | 132,050 | 0.0% | 0.27% | -11.1% |
| Q2 2014 | $2,726,000 | -5.2% | 132,050 | 0.0% | 0.31% | -9.7% |
| Q1 2014 | $2,877,000 | -14.0% | 132,050 | +4.8% | 0.34% | -18.1% |
| Q4 2013 | $3,344,000 | +12.3% | 126,050 | 0.0% | 0.41% | +3.5% |
| Q3 2013 | $2,979,000 | +9.9% | 126,050 | 0.0% | 0.40% | -1.7% |
| Q2 2013 | $2,710,000 | – | 126,050 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |